Drugs / DSP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03754049 Comparator | Jan 2019 → Nov 2023 | osteoarthritis, knee | Taiwan Liposome Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DSP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03754049 ↗ |
| Modality | Other / unclassified | “glucocorticoid” NCT03754049 ↗ |
| Route | Other | “via IA injection” NCT03754049 ↗ |